SeraNovo, the formulation startup from Leiden, received a € 300,000 investment from UNIIQ. The investment was announced during Innovation for Health. SeraNovo’s mission is to enable new oral medicines by solving bioavailability issues. Poor drug solubility affects almost all of the small molecules currently in development and results in many viable medications never reaching patients. SeraNovo’s Eutech platform is a fundamentally new and superior approach to this problem.
Read the press release for more information (in Dutch).